LEVELS AND METHODS OF PUBLIC FINANCING OF TB SERVICE IN ARMENIA

Similar documents
Ambulatory Care Day 1 for Multidrug Resistant Tuberculosis

Terms of Reference Kazakhstan Health Review of TB Control Program

A people-centred model of TB care

Role of National TB Program in LTBI Reseach. Dr Hung, Vietnam

Strategy of TB laboratories for TB Control Program in Developing Countries

Changing the paradigm of Programmatic Management of Drug-resistant TB

Patients and TB: Improving treatment outcomes through a patient centred approach and access to new treatments

ENGAGE-TB. Operational Guidance M&E. Paris, 2 November ENGAGE-TB Operational Guidance November 2, 2013

Financial impact of TB illness

Programmatic Management of MDR-TB in China: Progress, Plan and Challenge

Extensive review of tuberculosis prevention, control and care in Armenia July 2014

Dyah Erti Mustikawati

Models of care for multidrug-resistant tuberculosis

Tuberculosis (TB) risk assessment worksheet

Extensive Review of TB Prevention, Care and Control Services in

Review of the national tuberculosis programme in Belarus

Priority programmes and rural retention the example of TB. Karin Bergstrom Stop TB Department WHO, Geneva

FAST. A Tuberculosis Infection Control Strategy. cough

Psychiatric care in Switzerland: recent evolutions and perspectives. P. Giannakopoulos

Tuberculosis surveillance in Suriname. Drs. B. Jubithana, MD M. Wongsokarijo, MSc

Importance of the laboratory in TB control

Scaling up patient centered outpatient models of care for M/XDR-TB cases in Uzbekistan. Nargiza Parpieva Uzbekistan

Grant Aid Projects/Standard Indicator Reference (Health)

Procurement and supply management report for the WHO European Region, high MDR-TB priority countries, 2013

Management of patients with TB/HIV Gunta Kirvelaite

KEY ACTIVITIES IN TB CONTROL. Using Epidemiology for Data-Driven Decision-Making in Tuberculosis Programs February 24, 2016

Tuberculosis Regional Eastern European and Central Asian Project (TB-REP) Mid-term update

Public Private Mix sub group meeting 23 October, 2011 Scale up PPM in Myanmar

Philippine Strategic TB Elimination Plan: Phase 1 (PhilSTEP1)

A PEOPLE-CENTRED MODEL OF TB CARE

MONITORING AND EVALUATION PLAN

THE FIRST NATIONAL TB PATIENT COST SURVEY IN VIETNAM (2016) Nguyen Binh Hoa, MD., PhD Viet Nam NTP

Epidemiological review of TB disease in Sierra Leone

Summary of the Evaluation Study

RWANDA S COMMUNITY HEALTH WORKER PROGRAM r

Strengthening and Aligning Diagnosis and Treatment of Drug Resistant TB in India

Republic of Indonesia

Successful treatment of MDR-TB in Baja California

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 537 of 593

Discussion notes: Breakout group on developing a Patient Centred Approach (PCA) to TB management

Systematic Engagement of Hospitals Philippine Experience. Dr. Marl Mantala 8 th PPM Sub-group Meeting, 10 Nov. 2012, Kuala Lumpur

Working Paper Series

RIT/ JATA Philippines, Inc. Activities and Accomplishments. STOP TB Partnership Forum Asia March 14-15, 2016

TUBERCULOSIS CONTROL RESEARCH MATRIX

5 th Regional TB Symposium 22/23 March 2016 Courtyard Marriott Hotel, Tbilisi, Georgia

OPERATIONAL RESEARCH. What, Why and How? Dr. Rony Zachariah MD, PhD Operational Centre Brussels MSF- Luxembourg

Primary health care reform in Ukraine: priorities and perspectives

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.

Nepal s National Tuberculosis Control Program

TB Infection Control: Accomplishments, challenges, and setting priorities

WHO Task Force Framework on assessment of surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO / STB /TME June 2010

Practical Aspects of TB Infection Control

Responsibilities of Public Health Departments to Control Tuberculosis

Hospital engagement lessons from the five-country WHO/CIDA initiative

2016 PHYSICIAN QUALITY REPORTING OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY

Improving the estimates of childhood TB disease burden and assessing childhood TB activities at country level

Measurement of TB Indicators using e-tb Manager (TB Patient Management Information System)

WHO/HTM/TB/ Task analysis. The basis for development of training in management of tuberculosis

2) The percentage of discharges for which the patient received follow-up within 7 days after

Administrative Without, TB control fails. TB Infection Control What s New? Early disease prevention Modern cough etiquette

Empowering States & Districts & using biometric technology to deliver healthcare to the doorsteps of the poor

Critical Appraisal of Tuberculosis Dots Diagnostic Centers in Lahore District

Facility Tuberculosis (TB) Risk Assessment for Correctional Facilities

Momentum on Child TB: South East Asia (SEA)

2012 TB Laboratory Specimen Referral, Reporting & Transportation for diagnosis and management of MDR TB (January to June 2012)

Performance of RNTCP NTI Bulletin 2003, 39 / 3&4, 19-23

STATE PROGRAMME F"DENSAULYK" FOR HEALTH CARE SYSTEM DEVELOPMENT IN REPUBLIC OF KAZAKHSTAN

Heading Towards a COPD Care Pathway

ARMENIA. October By: Askar Yedilbayev

PPM Subgroup Meeting: Lille

TB Transmission Risk Reduction

Southwest Texas Regional Advisory Council

FEDERAL MINISTRY OF HEALTH DEPARTMENT OF PUBLIC HEALTH. National Tuberculosis and Leprosy Control Programme. A Tuberculosis Infection Control Strategy

TB CONTROL STRATEGIC PLAN FOR GHANA

Overview: TB Case Management and Contact Investigation

Request for Proposals. For. Sub-award. in support of. Challenge TB East Africa Region. Cross Border TB initiative

Subaward for Patient-Based Organization to Increase Community Awareness and Reduce TB-Related Stigma in DKI Jakarta

GLOBAL FUND ROUND 6 TB GRANT CLOSURE REPORT

PROJECT INFORMATION DOCUMENT (PID) APPRAISAL STAGE Report No.: PIDA2678. Project Name. Region. Country

Refining the Hospital Readmissions Reduction Program. Mark Miller, PhD Executive Director December 6, 2013

Trends in hospital reforms and reflections for China

Report of the Joint Working Group on Health and Related Social Issues (JWGHS) for

FEDERAL MINISTRY OF HEALTH

Emergency admissions to hospital: managing the demand

FEDERAL MINISTRY OF HEALTH NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME TERMS OF REFERENCE FOR ZONAL CONSULTANTS MARCH, 2017

Partnerships for Success: Laboratories and Programs Meeting the Challenge. Partnerships During a TB Outbreak

Using An APCD to Inform Healthcare Policy, Strategy, and Consumer Choice. Maine s Experience

Tuberculosis: Surveillance and the Health Care Worker

Second Africa TB Regional Conference on Management of TB Medicines. Africa TB Conference 2012, Zanzibar December 5-7, 2012

Staffing Your TB Program

Universal Access to MD TB Program in Cambodia. ITM, Antwerp 08 December Sam Sophan Cambodian Health Committee (CHC)

Edited by: ipierpaolo de Colombani. Review of the National Tuberculosis Programme in Belarus

Accelerating scale up of MDR-TB treatment in TB CARE countries

MBHP FISCAL YEAR 2011 MID-YEAR PROVIDER RATE INCREASES AND INCENTIVES

Kenya Joint TB/HIV Concept Note Development. Newton Omale Global Fund Manager National TB Program Ministry of Health

Request for proposals (RFP) For. Operational Research on Tuberculosis. in support of. Challenge TB Project in Tanzania. Issuance Date: 30/1/2018

Effect of Delay in Tuberculosis Diagnosis on Pre-Diagnosis Cost

The National Health Insurance Program Benefit Packages

Basile Keugoung 1*, Jean Macq 2, Anne Buve 3, Jean Meli 4 and Bart Criel 3

Leaving on a jet plane: My patient is leaving. What do I do?

Transcription:

Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology and Tuberculosis, and Médecins Sans Frontières 1-2 March, 2017, MINSK, BELARUS LEVELS AND METHODS OF PUBLIC FINANCING OF TB SERVICE IN ARMENIA KARAPET DAVTYAN, MD, MPH, MBA NTBCC, Armenia

TB EPIDEMIOLOGY IN ARMENIA (2007-2016) 80 70 60 50 40 30 20 10 0 MDR TB/HIV Morbidity Mortality 5.4 4.3 3.9 2.9 1.4 2 1.6 1.6 1.6 1.6 62.3 63.6 61.2 57 50.9 49.4 46 39.3 36.1 33.2 0.25 0.37 0.52 0.52 1.5 2.6 2.2 3 2.6 1.5 1.8 2.4 4.1 4.1 2.7 3.3 3.4 3 2.7 2 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Per 100000 population 2

PUBLIC FUNDING OF TB SERVICES Fully covered by public funding through the State Health Agency of MOH. In-patient services TB services in Armenia TB Diagnostic services Out-patient services 3

OBJECTIVES OF THE FINANCING ADJUSTMENTS FOR TB SERVICES To reduce high level of unjustified hospitalization rate for TB patients To ensure effective and targeted use of funds Strengthen TB out-patient service 4

CHANGES IN TB FINANCING MECHANISMS IN ARMENIA Bed/Day Fixed + Variable Costs In-patient FINANCIAL INCENTIVES FOR HOSPITALIZATION Fixed costs (70%) Variable costs NO MORE FINANCIAL INCENTIVES FOR HOSPITALIZATION TB services Better Performance Fixed Funding, Per/Capita-Based Fixed + Performance Based Out-patient DO NOT MOTIVATES PERFORMANCE Per/capita costs Performance based MOTIVATES PERFORMANCE 5

REVISED FINANCING MECHANISMS FOR IN-PATIENT TB SERVICES Fixed Costs (provision of facility maintenance costs such as wages, utilities etc.) + Variable Costs (cost of medicine and food based on the number of discharged patients) 6

PROCESS OF CHANGING METHODS OF FINANCING OF THE TB INPATIENT SERVICE ASSESSMENT/STUDY IN TB SERVICE NTC HSA INTRODUCTION OF RESULTS TO THE MOH NTC HSA POLITICAL COMMITMENT WILLING TO CHANGE GOVERNMENT ORDER MOH/NTC/HSA ADOPTED BY THE GOVERNMENT OF ARMENIA INTRODUCTION IN HEALTH SYSTEM PRECEDENTFOR PSYCHIATRIC AND NARCOLOGIC SERVICES M & E /NTC-HAS, WHO/ 7

ACHIEVEMENTS Introduced new hospitalization criteria for TB patients Reduced Number of hospitalized TB patients and hospitalization rate of TB patients Number of hospitalized TB suspects and TB patients with smear negative results Average length of stay (ALOS) for suspects and smear negative TB patients in hospital Bed Occupancy Rate (BOR) 8

EXAMPLE: NID INDICATOR 7000 6000 5000 4000 3000 2000 1000 0 Number of inpatient discharges 6513 5581 4388 2703 2013 2014 2015 2016 9

EXAMPLE: BOR INDICATOR 100.0% 90.0% 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% Bed Occupancy Rate (BOR) 72.0% 54.0% 52.0% 36.0% 2013 2014 2015 2016 10

EXAMPLE: ALOS INDICATOR 45.0 40.0 35.0 30.0 25.0 20.0 15.0 10.0 5.0 0.0 Average Length of Stay (ALOS) 37 23.0 22.2 22.6 2013 2014 2015 2016 11

MONITORING AND EVALUATION OF THE TB SERVICE FINANCING REFORM TB SERVICE MANAGEMENT JOINT WHO EURO-SHA ARMENIA- NTC ARMENIA (WOLFHESE WORKING GROUP) FINANCING INDICATORS 12

TB SERVICE MONITORING INDICATORS N INDICATORS 2013 2014 2015 2016 1 Percentage of completed or cured 80.0% 77.2% 79.3% 79,6% 2 Retreatment TB rate 22.6% 25.8% 23.6% 24.3% 3 Percentage of people diagnosed among those screened and tested 33.4% 38.3% 38.3% 32.0% 4.1 Cost per patient treated for drug susceptible patients (AMD, thousands) 144.1 159.2 298.7 298.7 4.2 Cost per patient treated for MDR patients (AMD thousands) 323.4 338.1 351.9 351.9 5 Percentage of lost patients 9.8% 11.7% 6.7% 8.5% Cost per sucessfully treated (completed treatment or cured) drug 6.1 susceptible TB patient n.a. n.a. n.a. n.a Cost per sucessfully treated (completed treatment or cured) M/XDR-TB 6.2 patient n.a. n.a. n.a. n.a 7 Bed Occupancy Rate (BOR) 72.0% 54.0% 45.0% 36.0% 8 Average Length of Stay (ALOS) 23 22.2 22.6 37 9 Number of inpatient discharges 6513 5581 4388 2703 406.8 226.6 233.8 406.8 10 Cost per inpatient discharge (AMD thousands) 11 Inpatient readmissions rate in 30 days 2.99% 2.63% 3.23% 1.33% 12 Admission rate of new smear positive patients 98.00% 98.40% 89.70% 95% 13 Case detection rate in outpatient facilities 2.00% 1.62% 9.88% 12.0% 14 Percentage of DR-TB patients followed in outpatient facilities 144.80% 218.50% 294.00% 13

TB SERVICE MONITORING INDICATORS N INDICATORS 2013 2014 2015 2016 15 Physicians visits per 100.000 inhabitants 394,559 395,933 406,813-16 Medical visits per outpatient n.a. n.a. n.a. n.a 17 Cost per medical visit (AMD thousands) 2.5 2.6 2.7 2.7 18 Percentage of patients treated exclusively in outpatient settings 8.00% 14.80% 15.70% 11% 19 Cost per outpatient 157.2 148.8 155 155 20 Joint assessment of resource allocation and efficiency indicators by the NTP and SHA Ongoing Ongoing Ongoing 21 External assessment of the implementation and impacts of health finance reforms 22 Inpatient discharges per 10.000 inhabitants 21.5 18.5 14.6 23 Percentage of smear negative patients that are hospitalized 0.67 0.298 0.297 0.49 24 Change in percentage of resources allocated to outpatient care -3.40% -0.20% - 25 Percentage of physicians trained for people centered care and offered by the NTC 98.10% 98.10% 100% 26 Percentage of nurses trained for people centered care and offered by the NTC 100% 100% 100% 27 Number of hospital beds for TB 428 428 428 398 28 Inpatient physicians (FTE) per 10.000 inhabitants 0.086 0.099 0.116 0.144 29 Inpatient nurses (FTE) per 10.000 inhabitants 0.55 0.56 0.5 0.5 30 Percentage of funding allocated to Inpatient Care 76.60% 80.00% 80.20% 80..2% 31 Physicians (FTE) providing outpatient services per 10.000 inhabitants 0.25 0.25 0.3 0.3 32 Outpatient nurses (FTE) providing outpatient services per 10.000 inhabitants 0.29 0.28 0.3 0.3 33 Percentage of funding allocated to Outpatient Care 23.40% 20.00% 19.80% 19.8% 14

FUTURE ACTIVITIES Regularly monitoring and evaluation Establishment of a Continuous Quality Improvement System at the National Tuberculosis Control Center Data management, including the traceability of the documentation Standardization of procedures and SOP document development Qualification of service providers/staff trainings New Training center for TB service management best practices in Armenia Introduction of the implementation of new model of DOT at home with the support of family members based on results of study Patient-centered TB treatment approach: A cluster randomized controlled trial in Armenia implemented by AUA and NTBCC Redesigning the Yerevan CTBD to the Center of Lung Diseases and Tuberculosis 15

CONTINUOUS QUALITY IMPROVEMENT SYSTEM 16

A CLUSTER RANDOMIZED CONTROLLED TRIAL IN ARMENIA 17

THANK YOU! 18